IXICOLSE:IXI Days Payable is 87.25 as of Mar. 2026, which is 47% below its 10-year median of 165.59. The stock has 2 warning signs investors should review. Among 706 Biotechnology companies, IXICO ranks worse than 50.85% on this metric.
IXICO's average Accounts Payable for the
six
months ended in Mar. 2026 was £0.88 Mil. IXICO's Cost of Goods Sold for the
six
months ended in Mar. 2026 was £1.85 Mil.
Hence, IXICO's Days Payable for the
six
months ended in Mar. 2026 was 87.25.
The historical rank and industry rank for IXICO's Days Payable or its related term are showing as below:
LSE:IXI'
s Days Payable Range Over the Past 10 Years
Min: 8.6 Med: 165.59 Max: 269.76
Current: 111.24
During the past 13 years, IXICO's highest Days Payable was 269.76. The lowest was 8.60. And the median was 165.59.
LSE:IXI's Days Payable is ranked worse than 50.85% of 706
companies
in the Biotechnology industry
Industry Median: 113.56
vs LSE:IXI: 111.24
IXICO's Days Payable
declined
from Mar. 2025 (89.67) to Mar. 2026 (87.25).
It may suggest that IXICOaccelerated paying its suppliers.
IXICO Days Payable Related Terms
IXICO Days Payable Historical Data
* Premium members only.
The historical data trend for IXICO's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:IXI vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, IXICO's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IXICO Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IXICO's Days Payable distribution charts can be found below:
* The bar in red indicates where IXICO's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
IXICO's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IXICO (LSE:IXI) has a Days Payable of 87.25 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IXICO and its competitors. This is 47% below median its historical median of 165.59. Over the past decade, IXICO's Days Payable has ranged from 8.60 to 269.76. According to the industry distribution chart, IXICO ranks #359 out of 706 companies in the Biotechnology industry, placing it in the top 50.8%.
Is IXICO's Days Payable too high?
IXICO's current Days Payable of 87.25 is 47% below median its 10-year median of 165.59. Over the past 10 years, this metric has ranged from a low of 8.60 to a high of 269.76. The Biotechnology industry median Days Payable is 113.56. IXICO's value of 87.25 is 23.2% below this industry median. Based on the distribution chart, IXICO ranks #359 out of 706 companies in the Biotechnology industry, which is below the industry midpoint.
How does IXICO's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, IXICO ranks #359 out of 706 companies for Days Payable. This places IXICO in the lower half of its industry. The industry median Days Payable is 113.56. IXICO's value of 87.25 is 23.2% below this benchmark. Historically, IXICO's own Days Payable has ranged from 8.60 to 269.76 over the past decade. While the company's 10-year median is 165.59 vs. the industry median of 113.56, IXICO has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IXICO's current Days Payable of 87.25 is 23.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IXICO and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IXICO's current Days Payable is 87.25, which is 47% below median its own 10-year median of 165.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
Based on GuruFocus' analysis, IXICO (LSE:IXI) is currently considered Fairly Valued. The stock's GF Value™ is £0.08, compared to a current price of £0.08 — trading 5.6% above its estimated fair value. The current Days Payable is 87.25, which is 47% below median its 10-year median of 165.59 and 23.2% below the Biotechnology industry median of 113.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For IXICO (LSE:IXI), the current Days Payable is 87.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IXI has been successfully added to your 